03:00 Tue 24 Mar 2020
OptiBiotix Health - Extension of territories for GoFigure®
OptiBiotix Health plc
("OptiBiotix" or the "Company")
Extension of territories for GoFigure®
with Extensor
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces it has extended the territories of its original distribution agreements with Extensor
Extensor is OptiBiotix's exclusive partner in
Dr.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
For further information, please contact:
|
||
|
Contact via Walbrook below |
|
|
|
|
|
Tel: 020 7213 0880 |
|
|
|
|
|
|
|
finnCap (Broker) |
Tel: 020 7220 0500 |
|
|
|
|
|
|
|
|
|
|
goetzpartners securities Limited |
Tel: 0203 859 7725 |
|
|
|
|
|
|
|
|
Mob: 07876 741 001 |
|
|
|
|
About OptiBiotix - www.optibiotix.com
OptiBiotix has an extensive R&D program working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE